This post is the first in a series about the Clinicaltrials.gov website. This piece is an interview the Director, Dr. Deborah Zarin. I want to thank her for taking the time to answer my questions. Later, I will post Part 2 in which I discuss my concerns about the trend of for-profit stem cell clinic trials …
Interview with Clinicaltrials.gov Director Deborah Zarin Read More »
What’s the deal with Brigham and Women’s Hospital or Harvard Medical School, where STAP cell senior author works, when it comes to the retracted STAP cell papers? I was just writing yesterday in part about how we haven’t really heard anything (news, statements, etc.) from those places about the whole STAP cell mess. In contrast, in Japan …
STAP News From Harvard? Vacanti Stepping Down as Chair & Going on Sabbatical Read More »
The Obokata STAP cell papers in Nature were retracted today. It feels like it’s been a long time coming in one way as for months now it has felt like retraction was inevitable, but it’s been extraordinarily fast in another way as retractions almost never happen this fast. It’s a day of mixed feelings. This …
Perspectives on STAP cell Nature paper retractions Read More »
I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network. It’s an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers …
Cell Surgical Network Series Part 3: Key Concerns Read More »
Occasionally I call out a particularly important comment by a reader on a major issue and today it is commenter Natalie DeWitt (see my earlier interview with her about her experiences at Nature’s The Niche) who has contributed a particularly insightful, knowledgable comment on my recent perspective piece the Cell cloning paper mishap. Many in the …
Natalie DeWitt Must-Read Comment on Cell Cloning Paper Mishap Read More »
One of my inspirations as a stem cell blogger was the pioneering Nature blog, the Niche. I was disappointed when it ended in 2009, but it still is a model of what excellence in science blogging is all about. In this piece today, I interview the co-Founder of the Niche, Dr. Natalie DeWitt. DeWitt now …
Interview with Natalie DeWitt, Founder of Nature’s pioneering stem cell blog, the Niche Read More »
Next month will be the 1st Houston Stem Cell Summit organized by Robin Young, who also organizes the New York Stem Cell Summit. I’ve been a bit tough on this meeting for a perceived lack of diversity in their program of speakers. I interviewed Robin Young (RY) about the meeting and found his answers quite interesting …
Intriguing interview with Robin Young, Organizer of Houston Stem Cell Summit Read More »
Obtaining research grant funding is a critical part of science, but the process seems to be getting more challenging each year. Funding rates are decreasing. Applicant frustration is increasing and many grant applicants tell me they feel confused about the differences between funded and unfunded proposals. The largest funder of biomedical research in the U.S. …
Interview with NIGMS Director, Jeremy Berg, part 1: grant advice, meritocracy Read More »
What are the most important iPS cell papers so far? 1) Yamanaka’s first paper on mouse iPS cells. Revolutionary. Intriguing perspectives presented in day 1 of the iPS cell field. Interesting statements such as Myc is required. Also take a look at those other reprogramming factors that he tested…there’s a tremendous amount there, largely unexamined. …
I took a poll of my blog readers on how strongly they feel about open access. Is open access more than a buzzword? Are scientists willing to go beyond talk and take actions? If the results of the poll are any indication the message is that most scientists are indeed changing their publishing habits to …
Are scientists willing to take action for open access publishing? See our poll results Read More »